Comparison of immunohistochemical and biochemical determination of estrogen receptors in mammary carcinoma;Cáncer de la mama: Comparación entre la determinación bioquímica e inmunohistoquímica de los receptores de estrógenos
Systemic treatment of early breast cancer by hormonal, citotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women
EARLY BREAST CANCER TRIALISTS' COLLABORATIVE GROUP. Systemic treatment of early breast cancer by hormonal, citotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339: 1-15, 71-85.
Immunohistochemical determination of estrogen and progesterone receptor status in breast cancer
TESCH M, SHAWWA A, HENDERSON R. Immunohistochemical determination of estrogen and progesterone receptor status in breast cancer. Am J Clin Pathol 1993; 99: 8-12.
Immunocytochemical estrogen and progestin receptors assays in breast cancer with monoclonal antibodies
PERTSCHUK LP, KIM DS, NAYER K ET AL. Immunocytochemical estrogen and progestin receptors assays in breast cancer with monoclonal antibodies. Cancer 1990; 66: 1663-70.
Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma
HELIN H, HELLE M, KALLIDNIEMI O, ISOLA J. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Cancer 1989; 63: 1761-67.
Immunohistochemical analyses of estrogen receptors using formalin-fixed paraffin-embedded breast cancer tissue; correlation with clinical response
ANDERSEN J, SKOVGAARD P. Immunohistochemical analyses of estrogen receptors using formalin-fixed paraffin-embedded breast cancer tissue; correlation with clinical response. J Steroid Biochem 1988; 30: 337-9.
Estrogen receptors analysis on biopsies and fine-needle aspirates from human breast carcinoma
REINER A, SPONA J, REINER G. Estrogen receptors analysis on biopsies and fine-needle aspirates from human breast carcinoma. Am J Pathol 1986; 125: 443-9.
Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimens from patients with breast cancer
MASOOD S. Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimens from patients with breast cancer. Arch Pathol Lab Med 1989; 113: 26-30.
Prediction of endocrine response in breast cancer by immunocytochemical detection of estrogen receptor in fine-needle aspirates
COOMBES R, POWLES T. Prediction of endocrine response in breast cancer by immunocytochemical detection of estrogen receptor in fine-needle aspirates. Lancet 1987; II: 701-3.
Suppression of endogenous avidin-binding activity in tissues and relevance to biotin avidin systems
WOOD G, WARNKE R. Suppression of endogenous avidin-binding activity in tissues and relevance to biotin avidin systems. J Histochem Cytochem 1981; 29: 1196-1201.